1.Anatomical variability of the left spermatic vein and establishment of the experimental left varicocele model in adolescent rats.
Bing YAO ; Da-Yu HAN ; Chun-Hua DENG ; Bin OUYANG ; Xiang-Zhou SUN ; Sheng-Fu CHEN ; Qi-Yun YANG
National Journal of Andrology 2014;20(6):505-509
OBJECTIVETo identify the anatomical variability of the left spermatic vein (LSV) and determine its effect on the induction of experimental left varicocele (ELV) in adolescent rats.
METHODSWe equally randomized 30 adolescent male SD rats to groups A (LSV collaterals fully ligated and the left renal vein constricted), B (only the left renal vein constricted), and C (sham operation), observed the courses of the LSVs and measured their diameters. At 30 days after operation, we analyzed the changes in the left kidneys and the diameters of the LSVs.
RESULTSIrregular collaterals were observed in 90% of the LSVs and no abnormal changes were found in the left kidneys after surgery. The postoperative LSV diameter was remarkably increased in group A as compared with the baseline ([1.47 +/- 0.15 ] vs [0.16 +/- 0.08] mm, P < 0.01), but showed no significant difference in group B ([0.31 +/- 0.49] vs [0.15 +/- 0.07] mm, P > 0.05) and C ([0.17 +/- 0.07] vs [0.16 +/- 0.06] mm, P > 0.05), and it was significantly longer in A than in B (P < 0.01). The success rate of ELV induction was 100% in group A and 10% in group B, but no varicocele was observed in group C.
CONCLUSIONCorrect identification of the anatomical course of the LSV and ligation of its irregular collaterals are essential for the establishment of a stable and consistent ELV model.
Animals ; Disease Models, Animal ; Kidney ; pathology ; Ligation ; Male ; Rats ; Rats, Sprague-Dawley ; Spermatic Cord ; blood supply ; Varicocele ; Veins ; abnormalities
2.The comparison of the performance between third generation ELISA and fourth generation ELISA on acute and early HIV infection
Xiaoxu HAN ; Jinming OUYANG ; Hong SUN ; Zhenxing CHU ; Junjie XU ; Minghui AN ; Bin ZHAO ; Zhijun YANG ; Hong SHANG
Chinese Journal of Laboratory Medicine 2012;35(6):538-543
Objective To evaluate the performance of the third generation ELISA and the fourth generation ELISA for HIV-1 diagnosis assays on acute and early HIV-1 infected samples.Methods Sixtyseven acute/early HIV-1 infected samples were collected from the follow-up gays with seroconversion in Shen Yang city and from clinical patients in the First Affiliated Hospital of China Medical University with incomplete HIV-1 specific bands in western blot between 2008 and 2010.Third generation ELISA,fourth generation ELISA,western blot and HIV-1 viral load detecting were used for detecting these samples.The sensitivity,consistency were compared between third generation ELISA and fourth generation ELISA to detect the seroconversion samples and the window periods were abserved.Chi square test was used for statistical analysis.Results In the 67 acute/early HIV-1 infected samples,56 were HIV positive and 11 were HIV negative by the third generation ELISA.The sensitivity of the third generation ELISA was 83.6% (95% CI:72.5% -91.5%); 63 were HIV positive,1 was at gray zone and 3 were HIV negative by the fourth generation ELISA.The sensitivity of the fourth generation ELISA was 94.0% (95% CI:85.4% -98.3%),higher than the third generation ELISA(x2 =16.1,P <0.01).The consistency of the third generation ELISA and the fourth generation ELISA was 86.6% ( 95% CI:76.0% - 93.7%).The earliest third generation ELISA positive sample was the sample collected 16 days after HIV infection and the earliest fourth generation ELISA positive sample was the sample collected 9 days after HIV infection.There was significantly different on the window periods between the third generation ELISA and the fourth generation ELLSA Conclusion The fourth generation ELISA had a higher sensitivity and shorter window period on acute/early HIV infected samples than the third generation ELISA,which is more suitable for the HIV early infection screening on high risk populations.
3.Genome cloning of human bocavirus (HBoV1) and analysis of viral promoter activity.
Jingjing LI ; Bin SUN ; Jinfeng OUYANG ; Ying CHEN ; Hu HAN ; Kaiyu LIU ; Yi LI
Chinese Journal of Biotechnology 2011;27(6):909-916
Human bocavirus (HBoV) is a recently discovered parvovirus, which is suspected to be an etiologic agent of respiratory disease and gastrointestinal disease in human. In the present study, we screened 941 nasopharyngeal aspirates collected from hospitalized children with lower respiratory tract infections from October 9, 2007 to March 20, 2009 in the Children's Hospital of Hubei Province. Our results showed that 33 of 941 samples (3.51%) were detected positive for HBoV. To obtain a full-length HBoV clone, three segments which covered the nearly full-length genome were amplified by PCR from HBoV positive samples separately and cloned into pBluescript SK II vector, and the resulting plasmid was designated as pWHL-1 (GenBank Acession No. GU139423). We constructed the both EGFP and luciferase reporter gene vectors under the control of the HBoV unique promoter, respectively. Our data demonstrated that the HBoV promoter exhibited very high activity in all mammalian cells tested by fluorescent microscopy observation of the EGFP and luciferase activity assay and its strength was 4-5 fold higher compared to that of the CMV promoter. This work provided an excellent tool for further study of the mechanism of transcription and expression of the viral genome.
Base Sequence
;
Child, Preschool
;
Cloning, Molecular
;
Female
;
Genome, Viral
;
genetics
;
Human bocavirus
;
genetics
;
isolation & purification
;
Humans
;
Infant
;
Male
;
Molecular Sequence Data
;
Pneumonia
;
virology
;
Promoter Regions, Genetic
;
genetics
;
Sequence Analysis, DNA
4.A respondent-driven sampling survey on HIV and risk factors among men who have sex with men in Chongqing
Lin OUYANG ; Lian-Gui FENG ; Xian-Bin DING ; Jin-Kou ZHAO ; Jing XU ; Mei HAN ; Chao ZHOU
Chinese Journal of Epidemiology 2009;30(10):1001-1004
Objective To examine HIV prevalence and related risk factors among men who have sex with men(MSM) in Chongqing, and to explore the feasibility of using respondent-driven sampling (RDS) in the survey. Methods Based on results from formative research, a RDS survey was designed and conducted to collect demographic, behavioral and serologic data. RDSAT was used to calculate point estimation and confidence intervals. SPSS was used for bi-variate analysis using RDSAT exported weighed data. NETDRAW was used to draw network diagram. Results Among 617 subjects recruited, the adjusted HIV and syphilis prevalence rates were 16.8% and 10.9%, respectively. 73.0% of the subjects were 20 to 29 years old and 72.9% were officially registered residents of Chongqing. 83.4% were single, with the proportion of students the highest, accounting for 24.6%. During the last six months, 83.4% of them reported ever having anal sex, and 54.0% reported having unprotected anal sex. Conclusion This survey confirmed that Chongqing had a higher reported HIV prevalence among MSM than from other Chinese cities. Comprehensive intervention services were required to address this alarmingly high prevalence, with focus on intervention through internet and those having syphilis infection. RDS seemed one of the effective ways of recruiting hidden MSM populations in Chongqing which had a large population of active MSM who did not frequently visit MSM venues as compared with snowball method.
5.Finite element modeling of material property assignment based on CT gray value and its application in simulation of osteotomy for deformities.
Han-Bin OUYANG ; Pu-Sheng XIE ; Yu-Ping DENG ; Yang YANG ; Peng-Yu CHEN ; Hua-Jun HUANG ; Wen-Hua HUANG
Journal of Southern Medical University 2016;36(7):979-983
OBJECTIVETo explore a new method for finite element modeling to achieve material property assignment based on in situ CT gray value in simulated osteotomies for deformities.
METHODSA CT scan dataset of the lower limb of a patient with extorsion deformity was obtained for three-dimensional reconstruction using Mimics software and preparing a solid model. In the CAD software, the parameters for osteotomy simulation were defined including the navigation axis, rotation angle and reference plane. The tibia model was imported to the FEA pre-processing software for meshing procedure and then exported to Mimics. All the segments of the tibia meshed model were assigned uneven material properties based on the relationship between CT gray values and material properties in the Mimics software. Finally, all the segments of the tibia model, reference axis and reference plane were assembled in the pre-processing software to form a full finite element model of a corrected tibia, which was submitted to resolver for biomechanical analysis.
RESULTSThe tibia model established using our modeling method had inhomogeneous material properties based on CT gray values, and was available for finite element analysis for the simulation of osteotomy.
CONCLUSIONSThe proposed finite element modeling method, which retains the accuracy of the material property assignment based on CT gray value, can solve the reposition problem commonly seen in modeling via the routine method of property assignment and provides an efficient, flexible and accurate computational biomechanical analysis method for orthopedic surgery.
Finite Element Analysis ; Humans ; Models, Anatomic ; Osteotomy ; Software ; Tibia ; pathology ; Tomography, X-Ray Computed
6.Surveillance on HIV-1 incidence among men who have sex with men in Chongqing, China,2006-2008
Mei HAN ; Lian-Gui FENG ; Yan JIANG ; Sheng SHEN ; Hua LING ; Xian-Bin DING ; Lin OUYANG ; Jin-Kou ZHAO ; Yao XIAO ; Min ZHANG
Chinese Journal of Epidemiology 2009;30(9):878-881
n increasing trend.
7.Antioxidant Mechanism of Xiaojin Pill () for Treatment of Peyronie's Disease in Rats Based on Matrix Metalloproteinases.
Qiang GENG ; Fu WANG ; Qiang HAN ; Shao-Feng CHEN ; Bin OUYANG ; Zhong LI ; Yu ZHAO ; Qing-He GAO ; Guo-Jin YU ; Jun GUO
Chinese journal of integrative medicine 2019;25(9):671-676
OBJECTIVE:
To evaluate the effects of Xiaojin Pill () in the treatment of Peyronie's disease (PD) in a rat model.
METHODS:
Twenty-four male Sprague-Dawley rats were randomly divided into four groups with 6 in each: sham operation, PD model, vehicle control and Xiaojin Pill groups. The rats in the sham operation group received penile tunica albsginea (TA) injection with 50 μL vehicle, while the rats in the other 3 groups received 50 μL penile TA injection of 50 μg transforming growth factor (TGF)-β1. Forty-two days after the injection, rats in the vehicle control and Xiaojin Pill groups received 0.5 mL water and Xiaojin Pill solution (107 mg/kg of body weight), respectively by gavage for 28 days, while those in the sham operation and PD model groups did not receive any intervention. After intervention, the expressions of matrix metalloproteinase 2/9 (MMP2/9), nitric oxidesynthase (NOS), superoxide dismutase (SOD) and malondialdehyde (MDA) were measured.
RESULTS:
Rats in the PD model and vehicle control groups presented obvious fibrosis in corpus cavernosum (CC) and demonstrated a significantly increased expressions of MMP2 and MMP9 in the CC compared with the sham operation group (all P<0.01). In contrast, the expressions of MMP2 and MMP9 in the Xiaojin Pill group were significantly down-regulated (both P<0.01). In addition, the levels of NOS and MDA in CC were significantly increased while the activity of SOD was decreased in the PD model and vehicle control groups compared with the sham operation group (all P<0.01). After Xiaojin Pill treatment, the levels of MDA, NOS and SOD appeared to be corrected (all P<0.01).
CONCLUSIONS
Xiaojin Pill could reduce fibrosis in the CC by decreasing the expressions of MMPs, NOS and MDA, and by increasing the activity of SOD. Therefore, Xiaojin Pill might be a therapeutic option for PD.
8.High-Throughput Sequencing Technology for Detection of Gene Mutations in Myeloid Malignancies and Its Clinical Prognostic Significance.
Min OUYANG ; Bin JIANG ; Mei-Xiang ZHANG ; Wen-Qing HU ; Lin SHI ; Jian-Xin LIU ; Ya-Yun ZHANG ; Chun-Jian WANG ; Fang WANG ; Yao ZHANG ; Han-Yun REN
Journal of Experimental Hematology 2023;31(4):992-998
OBJECTIVE:
To detect the gene mutations in patients with myeloid malignancies by high-throughput sequencing and explore the correlation between gene mutations and prognosis.
METHODS:
A retrospective analysis was performed on 56 patients with myeloid malignancies who were hospitalized in the department of hematology, Peking University International Hospital from January 2020 to May 2021. The genetic mutations of the patients were detected by next-generation sequencing technology, and the correlation between the genetic mutations and prognosis of myeloid malignancies was analyzed.
RESULTS:
In 56 patients, the number of mutated genes detected in a single patient is 0-9, with a median of 3. Sequencing results showed that the most common mutated genes were RUNX1(21.4%), TET2(17.9%), DNMT3A(17.9%), TP53(14.3%) and ASXL1(14.3%), among which the most common mutations occurred in the signaling pathway-related genes (23.3%) and the transcription factor genes (18.3%). 84% of the patients carried multiple mutated genes (≥2), and correlation analysis showed there were obvious co-occurring mutations between WT1 and FLT3, NPM1 and FLT3-ITD, and MYC and FLT3. TP53 mutation was more common in MDS patients.The overall survival time of patients with NRAS mutation was significantly shortened (P =0.049). The prognosis of patients with TP53 mutation was poor compared with those without TP53 mutation, but the difference wasn't statistically significant (P =0.08).
CONCLUSION
The application of next-generation sequencing technology is of great significance in myeloid malignancies, which is helpful to better understand the pathogenesis of the disease, to judge the prognosis and to find possible therapeutic targets.
Humans
;
Leukemia, Myeloid, Acute/genetics*
;
Nucleophosmin
;
Prognosis
;
Retrospective Studies
;
High-Throughput Nucleotide Sequencing
;
Myeloproliferative Disorders
;
Mutation
9.Qilin pills combined with levofloxacin for asthenospermia accompanied with accessory sex gland infection: a clinical observation.
Yong GAO ; Zi WAN ; Xiang-Zhou SUN ; Ya-Feng LIU ; Ya-Dong ZHANG ; Bin OUYANG ; Sheng-Fu CHEN ; Tao ZHENG ; Xin CHEN ; Qi-Yun YANG ; Da-Yu HAN ; Bing YAO ; Chun-Hua DENG ; Xiang-An TU
National Journal of Andrology 2013;19(12):1115-1118
OBJECTIVETo observe the efficacy of the combination of Qilin Pills and levofloxacin in the treatment of asthenospermia accompanied with accessory sex gland infection.
METHODSWe randomly assigned 80 asthenospermia patients with accessory sex gland infection to groups 1 and 2 of equal number, the former treated with Qilin Pills + levofloxacin, and the latter with levofloxacin only. Qilin Pills were administered at the dose of 6 g tid for 30 days, and levofloxacin at the dose of 0.5 g qd for 20 days. We obtained semen parameters, including the percentage of progressively motile sperm and peroxidase-positive white blood cell (WBC) count, before and after medication, and compared the clinical effects between the two groups.
RESULTSAll the patients accomplished the clinical trial. The therapeutic effectiveness rates in improving progressive sperm motility were 60% in group 1 and 17.5% in group 2, with statistically significant differences between the two groups (P < 0.05). As for the peroxidase-positive WBC count in semen, the effectiveness rates were 87.5% and 82.5%, respectively, with no significant differences between the two groups (P > 0.05).
CONCLUSIONFor the treatment of asthenospermia accompanied with accessory sex gland infection, Qilin Pills combined with levofloxacin is evidently better than levofloxacin alone in improving sperm motility, and it has no obvious adverse effects.
Adult ; Asthenozoospermia ; complications ; drug therapy ; Drugs, Chinese Herbal ; therapeutic use ; Humans ; Infertility, Male ; drug therapy ; Levofloxacin ; therapeutic use ; Male ; Phytotherapy ; Reproductive Tract Infections ; drug therapy ; Treatment Outcome ; Young Adult
10.Lipid-lowering effects of oleanolic acid in hyperlipidemic patients.
Han-Qiong LUO ; Jie SHEN ; Cai-Ping CHEN ; Xiao MA ; Chao LIN ; Qiong OUYANG ; Chun-Xiao XUAN ; Jine LIU ; Hong-Bin SUN ; Jun LIU
Chinese Journal of Natural Medicines (English Ed.) 2018;16(5):339-346
Oleanolic acid (OA) is a pentacyclic triterpenoid compound extracted from olea europaeal, a traditional Chinese medicine herb. OA has been used in the clinic as a hepatoprotective medicine in China since 1970s. In our previous study, we observed that OA could ameliorate hyperlipidemia in animal models. In the present study, we conducted a small-scale clinical trial to evaluate the hypolipidemia effect of OA in hyperlipidemic patients. Hyperlipidemic patients were administrated with OA for four weeks (4 tablets once, three times a day). The blood samples of the patients were collected before and after OA treatment. The biological parameters were measured. Furthermore, three patients' blood samples were studied with DNA microarray. After OA administration, the TC, TG, and HDLC levels in serum decreased significantly. DNA microarray analysis results showed that the expressions of 21 mRNAs were significantly changed after OA treatment. Bioinformatics analysis showed 17 mRNAs were up-regulated and 4 mRNAs were down-regulated significantly after OA treatment. Five mRNAs (CACNA1B, FCN, STEAP3, AMPH, and NR6A1) were selected to validate the expression levels by qRT-PCR. Therefore, OA administration differentially regulated the expression of genes involved in lipid metabolism. The data showed a clinical evidence that OA could improve hyperlipidemia and also unveiled a new insight into the molecular mechanisms underlying the pharmacological effect of OA on hyperlipidemia.
China
;
Computational Biology
;
Drugs, Chinese Herbal
;
pharmacology
;
therapeutic use
;
Female
;
Gene Expression Profiling
;
Gene Expression Regulation
;
drug effects
;
Humans
;
Hyperlipidemias
;
blood
;
drug therapy
;
genetics
;
metabolism
;
Lipid Metabolism
;
drug effects
;
Male
;
Middle Aged
;
Oleanolic Acid
;
pharmacology
;
therapeutic use
;
RNA, Messenger
;
genetics
;
Treatment Outcome